MHRA cross-agency team outlines emerging considerations for the manufacture of personalised medicines
By Janine Jamieson2025-09-22T14:31:00
A cross-agency team of Quality and Clinical Trial assessors, Safety and Surveillance assessors, and Good Manufacturing Practice (GMP), Pharmacovigilance (PV) and Good Clinical Practice (GCP) inspectors at the UK Medicines & Healthcare products Regulatory Agency (MHRA) has been working closely with scientists from the MHRA Science Campus to develop and promote guidance for the manufacture of personalised medicines.